Quality, performance measures make haste slowly

Article

Washington--In November 1999, the Institute of Medicine (IOM) reported that as many as 98,000 Americans were being killed each year by medical mistakes and made recommendations it said could slash that rate in half within 5 years.

Despite a flurry of publicity and activity, including congressional hearings and increased funding for patient safety research, it hasn't happened, acknowledged Lucian Leape, MD, adjunct professor of health policy at the Harvard School of Public Health in Cambridge, MA, and a member of the IOM study committee that produced the report.

"The challenge still remains to ramp up efforts on a national scale, to generate stronger institutional leadership, and to spread the culture of quality to all organizations and individuals in the health care community, as well as to the policy makers who make decisions and appropriate funding related to health care," he said in an article published by IOM (JAMA 2005; 293:2384-90).

Reforms underway

Meanwhile, major developments are now underway that will affect all physicians, including urologists, in 2006.

Last July, Congress approved the Patient Safety and Quality Improvement Act, designed to encourage hospitals and health care providers to voluntarily report medical errors, serious adverse events, and their underlying causes to private patient safety organizations that contract with hospitals or other health care organizations to analyze their mistakes and develop methods of prevention.

Last month, the Centers for Medicare & Medicaid Services was to launch the Physician Voluntary Reporting Program (PVRP) to analyze the quality of care provided to Medicare beneficiaries by using a set of quality "G-codes" established by Medicare. Physicians will be asked to use these non-specialty-specific codes within the existing administrative system for their claims. (For details, visit http://www.cms.hhs.gov/PhysicianFocusedQualInits/)

CMS says it is working closely with "key stake holders," such as physician associations, consumer advocacy groups, philanthropic foundations, purchasers, and quality accreditation and quality assessment organizations, to develop and test the effectiveness of the project.

All of this is taking place as efforts to implement a new pay for performance system for Medicare reimbursement are being pushed by CMS and its advocates in Congress.

Last November, CMS Administrator Mark B. McClellan, MD, PhD, told the House Energy and Commerce Health Subcommittee that the system is broken and must be overhauled, that physicians face steep Medicare payment cuts over the next several years, and that taking arbitrary action to block those cuts won't work. A new system to reimburse physicians based on their efficiency and quality of care is needed, he declared.

Related Videos
Kevin M. Wymer, MD
Video 7 - "Multidisciplinary Collaboration and Expert Insights in the Management of Advanced Prostate Cancer"
Video 6 - "Emerging AR Targeting Agents and CDK4/6 Inhibitors in Metastatic Prostate Cancer and Potential Impact on the Treatment Landscape"
Video 5 - "Targeting the Androgen Receptor Pathway and Overcoming Treatment Resistance in Advanced Prostate Cancer"
Video 4 - "Androgen Receptor Signaling and Its Role in Driving Prostate Cancer Metastasis"
Video 3 - "Treatment Selection in Metastatic and Castration Resistant Prostate Cancer: Optimizing Outcomes and Preserving Patient Quality of Life"
Video 2 - "Predicting Risk and Guiding Care: Biomarkers & Genetic Testing in Prostate Cancer"
Video 1 - "Metastatic Prostate Cancer: Background and Patient Prognosis"
Related Content
© 2024 MJH Life Sciences

All rights reserved.